NR1H4 and intrahepatic cholestasis: The results showed that 8 serum differential biomarkers related to FXR deficiency-induced intrahepatic cholestasis were enriched to 6 metabolic pathways (Figure 6A; Table 2), mainly glycophoric metabolism and primary bile acid biosynthesis.